Search results

Kowa Pharmaceutical Europe AG is part of the Kowa Group, a global enterprise founded in 1894. Backed by over 130 years of innovation and expertise across pharmaceuticals, life sciences, trading, and manufacturing, we create value through quality, trust, and a worldwide network.

Chemgineering Switzerland AG is a consulting and planning company with focus on the GxP-regulated environment. Consulting, concept studies, turnkey solutions – we offer the full range of services in pharma, biotech, fine chemicals, cosmetics, diagnostics, food and more.

Heidelberger & Partners helps life sciences firms turn compliance into a strategic advantage. They enable strong compliance and governance, confident decisions with a practical, business-focused approach, offering IPO readiness (non-financial compliance), board governance, and interim CCO support.

Homax Advisory is a thought-leader and Independent Health Economic and Market Access consultancy for pharma and biotech. Vaud canton-based, serving clients across Europe.

Swiss Rockets is dedicated to developing groundbreaking medicines that transform the treatment of cancer, infectious diseases, and autoimmune disorders – advancing more effective, equitable, and accessible healthcare for patients worldwide.

European market entry partner for rare disease, ATMP and cell & gene therapy biotechs

Topadur Pharma AG (Schlieren, Zurich) is a clinical-stage biotech company developing small-molecule therapies that target impaired microcirculation and tissue regeneration. Its proprietary DualTOP® platform combines complementary pharmacological activities in single molecules for local use.

Looking for cheap lab space in Basel? Lambda Biolab (a service of Mackenzie-Lamb Consulting) offers affordable, fully equipped BSL-1 benches for researchers and biotech entrepreneurs for a fraction of the cost of traditional labs. Reduced rates for students, artists, and non-profits are available.

Independent advisor to CDMOs, private equity investors, and biotech companies on strategy, industrialization, and commercialization of advanced therapies and specialized manufacturing platforms, CGT manufacturing strategy, CDMO selection, Support financial investors and PEs with due diligences.

At Lederer & Partner AG, we transform complex visions into clear successful results. Our expertise in engineering, construction, commissioning, qualification, and operation, we develop project models that are precisely aligned with your goals. As your trusted partner, we deliver lean, efficient solutions.

Baker McKenzie is an international law firm with offices in Geneva and Zurich, offering top-tier legal advice across all areas of business law. Our team of 130 lawyers provides domestic and international clients with innovative solutions across 74 offices in 45 countries.

Life Science Cares Switzerland uses the innovation, financial and human resources of the life science industry to support local charitable projects. Main focus is promoting educational equity by providing young people from socially disadvantaged backgrounds with opportunities in our industry.

The grow Foundation provides small and large Life Sciences companies ready-to-use laboratories, offices, piloting and production facilities in Wädenswil/Horgen, in size ranging from a few working benches to several thousand m2.

Enzene is a fully integrated CIDMO with sites in Pune (India) & New Jersey (USA), offering discovery to commercial supply. Its EnzeneX™ FCCM™ tech leads next-gen biologics, aiming to cut mAb costs below $40/g by 2025. Learn more at www.enzene.com.

Xcube.bio builds organizations with late-stage innovative biopharma companies to enable the European market entry of life changing therapies. We create partners' own commercial footprint and revenue streams. Unique value proposition that open and de-risk the European market for innovative therapies.

ARTBIO is a clinical-stage radiopharmaceutical company focused on developing a new class of alpha radioligand therapies (ARTs) to transform cancer treatment. ARTBIO's approach centers on utilizing the alpha-emitting isotope Pb212 to target cancer cells while minimizing damage to healthy tissues.

FatiAbGen International is the Swiss subsidiary of FatiAbGen Inc., established in Korea in 2020. We engineer best in class antibodies tailored for multiple modalities such as ADCs and bi-specifics. We then develop targeted molecules to address high unmet need diseases in oncology and immunology.

PULSE is a state-of-the-art life sciences innovation center located in the Swiss Health Valley in Cheseaux-sur-Lausanne. Spanning 43,000 m², it hosts companies such as Thermo Fisher Scientific, Verdeya and Tibio, fostering a dynamic and collaborative ecosystem.

We are managing a portfolio of biotech opportunities, each selected based on promising science and potential for addressing unmet medical needs. Our team of industry-leading experts has extensive development & biotech experience which we put into practice to accelerate science into care.

Curie.Bio is a $1.2B VC founded to discover and develop important new medicines. We do that by investing directly into existing companies, creating focused spinouts, and helping founders build companies from scratch. Our team of >100 full-time drug hunters provides hands-on support to founders.

B Squared helps biotech and cell & gene therapy companies navigate complex CMC, manufacturing, and sourcing challenges. We bring hands-on expertise, real-world solutions, and a no-nonsense approach to getting things done.

Revolutionizing clinical trials, Trialize's cutting-edge automation platform accelerates study build times by 4x and curbs manual labor by up to 73%, enhancing data quality, patient adherence, and team morale. It's a game-changer in modern, decentralized, and virtual studies.

We at INCAPTEK are developing advanced drug delivery systems. We deliver drugs at the right place, in the right dosage, and at the right time. Our smart, programmed-shell micro(nano)capsules can be used for controlled and targeted drug delivery for both biotech and medtech.

Toxicology Consultant with >25 years of experience in the Biopharmaceutical Industry. I support Startup and Biotech Companies to advance their projects into the clinical phase. Get in touch to discuss your project when you have a shortage of nonclinical and toxicological expertise.

Volv Global is a healthcare AI company founded in 2017, generating new knowledge at speed to close diagnostic and care pathway gaps – enabling earlier diagnosis and better outcomes for patients with difficult-to-diagnose diseases, with data partners spanning 400 million patients worldwide.

EvlaBio is a life science startup dedicated to the development of first-in-class therapeutics in the cardiovascular and cardiorenal space. The lead asset is a Therapeutic Monoclonal Antibody (mAb) targeting unphysiological FGFR4/FGF23 cardiac overdrive in the setting of chronic kidney disease (CKD).

Azafaros is a clinical-stage biotech company addressing rare genetic lysosomal storage disorders with oral small molecules, including nizubaglustat. Our focus is on developing disease-modifying therapies for patients with, among others, GM1 and GM2 gangliosidoses, and Niemann-Pick Type C disease.

Pheida develops and deploys biotech solutions at scale to reduce GHG emissions and other pollutants, and to remediate contaminated soil and water. Pheida products combine advanced biotech, proprietary application engineering to deliver unique and commercially attractive solutions.

Horgen Labs: a life‑science campus on Lake Zurich offering 27,000 m² ready-to-use office, lab & production space plus 50,000 m² expansion land. Scale from startup to global player—near top universities, in a tranquil forest‑to‑lakeshore setting, backed by Swiss stability.

Citeline, a Norstella company, powers a full suite of complementary business intelligence offerings to meet the evolving needs of life science professionals to accelerate the connection of treatments to patients and patients to treatments.  

House of Lab Science provides plug-and-play lab infrastructure for biotech and foodtech startups across Switzerland. Our lab-as-a-service model offers ready-to-move-in, certified, well-equipped and affordable labs, helping teams start fast and scale from day one.

PolyPeptide Group is a focused Contract Development & Manufacturing Organization (CDMO) for peptide- and oligonucleotide-based active pharmaceutical ingredients. By supporting its customers mainly in pharma and biotech, it contributes to the health of millions of patients across the world.

Santersus AG is an innovative Therapeutic Apheresis company focused on using our patented technology for the cleansing of patient blood of cell free DNA and neutrophil extracellular traps (NETs) looking to revolutionize how we can control the human immune and inflammatory response to disease.

Zambon Biotech is part of the Zambon group, it is focused in growing the portfolio and pipeline of the Zambon group by entering into partnerships, acquiring assets and supporting their clinical development up to commercialization as well as licensing commercial stage assets.

Founded in 2012, headcount is a Swiss recruitment agency specializing in Biotech, Medtech, Pharma, and Digital Health. We combine scientific expertise with recruitment excellence to connect top talent with leading companies, ensuring a perfect cultural and professional fit.

Pharma-Consulting ENABLE GmbH provides support to biopharmaceutical companies (small & large) in product development and manufacturing covering early to late stage clinical and commercial operations. Pharma-Consulting ENABLE is active worldwide and has been created by Alain Pralong in 2008.

SENN is a real estate company and as such is developing the MAIN CAMPUS which is Switzerland’s largest life‑sciences campus in Allschwil. We’re developing five sustainable buildings by 2029 with flexible labs, offices and coworking spaces designed to accelerate ideas within a vibrant ecosystem.

Founded in 1998, the Swiss Biotech Association represents the interests of the Swiss biotech industry. To support its members, the association works to secure favorable framework conditions and facilitate access to talents, novel technologies and financial resources.

TargImmune Therapeutics AG is a private Swiss-based biotechnology company focused on drug development using novel targeted onco-immunotherapies.

valuationLAB AG is an independent life science research boutique. Our aim is to unlock value by translating complicated science into easy-to-understand financial forecasts and valuations, and sharing this with investors.

Venture Valuation specializes in independent assessments and valuations of companies and products, in biotech and life sciences, and runs the business development database Biotechgate with global licensing deals, and opportunities. To learn more: www.biotechgate.com and Biotechgate Digital Partnering: www.dig

Virometix AG is a privately held biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and chronic human diseases.

tiventa takes care for fresh air! Our mission is to clean the ventilation system in all kind of buildings, restaurants, industries, apartments and more. We are protecting people from airborne contaminants from entering room air and to maintain healthy indoor air quality.

Switzerland Global Enterprise (S-GE) links companies, experts and public organisations globally, thus facilitating efficient promotion of foreign trade. Apart from export promotion, S-GE is responsible for promoting Switzerland as a business location abroad.

Synple Chem was founded to develop new easy to use automated laboratory equipment for chemistry research labs.

SAKK is a non-profit organization since 1965 investigating the efficacy and tolerability of new cancer therapies and further develops existing tumor treatments in adults. Our objective is to apply the best possible treatment. We see ourselves as the Swiss competency center for oncology trials.

As an independent pharma consulting company, we have supported pharma and biotech companies since 2007. With a team of more than 25 consultants, Qualified Persons and support staff, three offices and hundreds of pharma partners in over 30 countries worldwide, we are ready to solve your challenges.

Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.

Novimmune SA has brought 7 monoclonal antibodies to clinical development stage, one of which, Emapalumab, has been approved by the FDA in 2018. We now focus on our bispecific technology to build a pipeline of multispecific antibodies under the brand Light Chain Bioscience.

Microsphere (MS) is a CDMO focused on new developments, cGMP manufacturing, R&D, analytical and regulatory support. MS is able to address complex challenges, including formulations for poorly water-soluble drugs, considering the extensive expertise in Spray Drying and Capsule Filling.

InSphero is the pioneer of industrial-grade, 3D-cell-based assay solutions and scaffold-free 3D organ-on-a-chip technology. InSphero supports pharmaceutical and biotechnology researchers in successful decision-making by accurately rebuilding healthy and diseased human physiology in vitro.

InterAx is a drug discovery firm spun out of ETHZ. Its Deep Signal platform combines AI with mechanistic cell signaling models to predict how drugs behave inside cells — designing medicines with better efficacy and fewer side effects. Pipeline spans metabolism and oncology, with pharma partnerships.

Helsinn is a global pharmaceutical company that builds, manufactures, launches, and commercializes products to improve the quality of life for patients with cancer and chronic disease, with a focus on supportive care, oncology and dermato-oncology.

HGF GmbH is a leading European intellectual property firm with a dynamic, forward-thinking growth strategy. Located in the heart of Switzerland’s innovation ecosystem, HGF’s Basel office is well positioned to support clients in highly regulated, research-intensive industries.

Calliditas is a commercial-stage biopharmaceutical company focused on novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with significant unmet medical needs. In 2021, Calliditas acquired Genkyotex, a French‑ and Swiss‑based company specializing in NOX therapies.

Future Health Pharma GmbH represents companies in Switzerland and distributes and markets their products in CH, UK and EU. We act as Marketing Authorisation Holder or establish their affiliate in CH and EU. We also hold an establishment license to handle controlled substances (narcotics) & vaccines.

evitria provides recombinant antibody production services based on CHO transient expression, focusing on bispecific, Fc-silenced, and afucosylated antibody formats. With over 140,000 transfections, we are a trusted partner for biotech and pharma worldwide.

We are a Swiss company promoting innovation and technology using our comprehensive and highly qualified expert knowledge. We offer company assessments and consulting and management to support all actors involved in “turning scientific innovation into successful products on the market”.

EffRx Pharmaceuticals SA is a commercial-stage pharmaceutical company, based in Switzerland, that develops and commercializes prescription medications for specialty indications. The primary focus is on therapeutics for men and women with musculoskeletal, genitourinary and rare diseases. Abiogen Pharma acquire

Curatis acquires, licences, distributes and promotes pharmaceutical products for the treatment and/or prevention of rare and speciality diseases in Switzerland. We have a promising pipeline of novel speciality care and orphan drugs for neurological disorders.

CRB is a leading design, construction and consulting firm serving life sciences companies globally since 1984. From small studies to execution of complex projects, we have the expertise to deliver solutions to our clients in the local pharmaceutical and biotechnology market.

At Biogen, we develop, market and manufacture therapies for people living with serious neurological, autoimmune and rare diseases.

We at Bioengineering AG design and build customized equipment to improve bioproduction efficiency in biotech, novel food, and biopharma plants. Our engineering teams develop reliable bioreactors and fermenters, from lab scale to production, for clients worldwide. Trusted for over 50 years. In 2025 Bioengineer

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN) is a commercial-stage biopharmaceutical company headquartered in Switzerland. Basilea is committed to discovering, developing and commercializing innovative drugs to meet the needs of patients with severe bacterial and fungal infections.

ADIENNE is an integrated biopharmaceutical group of companies based in Lugano, Switzerland, with a proprietary portfolio of orphan-designated marketed medicinal product, clinical and preclinical product candidates focusing on critical conditions of high unmet medical needs.

Kuhner AG is a leading developer and manufacturer of shaking machines, single use bioreactors, automation systems and online measuring technology for the international market. Furthermore, Kuhner sales lab-equipment (freeze dryers, centrifuges, etc.) to the Swiss market.